エピソード

  • US Opioid Deaths Drop 32% as Buprenorphine Prescriptions Surge: What's Working in 2025

    US Opioid Deaths Drop 32% as Buprenorphine Prescriptions Surge: What's Working in 2025
    2026/04/26
    The opioid epidemic in the United States, once spiraling out of control, is finally showing signs of hope with overdose deaths plummeting from over 110,000 in 2023 to around 75,000 in 2025, according to the American Medical Association's latest report. Listeners, this marks a significant turnaround after years of devastation driven by illicit fentanyl and deadly drug mixes.

    In the middle of this story, progress stems from smarter treatments and policies. The AMA reports prescriptions for buprenorphine, a lifesaving medication for opioid use disorder, surged from 1.4 million in 2012 to 15.4 million in 2024, though gaps persist due to stigma and red tape. Opioid prescriptions themselves halved to 125.7 million, shifting focus to nonopioid pain care. Naloxone access is expanding via over-the-counter sales and community programs, while states like Colorado, Illinois, Virginia, and Washington lead with laws boosting treatment parity and youth prevention. Yet challenges loom: nearly 60% of deaths involve multiple substances like stimulants, xylazine, and even kratom, making the drug supply more toxic than ever. A Weill Cornell Medicine survey reveals 88% of Americans across political lines see this as a crisis, though conservatives lean toward personal responsibility while liberals point to pharmaceutical companies. The Congressional Budget Office echoes calls for federal steps like enhancing prescription monitoring, expanding Medicaid treatment, and disrupting illicit supply chains, which have already cut hospital admissions.

    Looking ahead, the AMA urges decisive action: scrap prior authorizations, enforce mental health parity with real penalties, and ramp up surveillance on emerging threats like polysubstance use and cannabis disorders. Physicians, policymakers, and communities must unite with science and compassion to sustain this momentum.

    Thank you, listeners, for tuning in. Come back next week for more. This has been a Quiet Please production, and for me, check out Quiet Please Dot A I.

    Some great Deals https://amzn.to/49SJ3Qs

    For more check out http://www.quietplease.ai

    This content was created in partnership and with the help of Artificial Intelligence AI
    続きを読む 一部表示
    2 分
  • # US Opioid Deaths Drop 38% as Buprenorphine Access Expands, But Fentanyl and New Threats Persist

    # US Opioid Deaths Drop 38% as Buprenorphine Access Expands, But Fentanyl and New Threats Persist
    2026/04/23
    The opioid epidemic in the United States is showing signs of progress after years of devastation, with overdose deaths dropping nearly 38% from 109,703 in October 2023 to 68,408 in October 2025, according to provisional data from the U.S. Centers for Disease Control and Prevention cited by the American Medical Association. Despite this decline, the crisis remains deadly and evolving, fueled primarily by illicitly manufactured fentanyl, which drove most of the roughly 75,000 opioid-related deaths in 2025, as detailed in a recent AMA report. Nearly 60% of these fatalities now involve polysubstance use, making the illegal drug supply more toxic and unpredictable than ever, warns AMA CEO John Whyte.

    Listeners, the good news stems from expanded access to life-saving treatments like buprenorphine, with prescriptions surging from 1.4 million in 2012 to 15.4 million in 2024, per the AMA. Groups like the AMA, American Society of Addiction Medicine, and American Pharmacists Association emphasize that affordable, evidence-based care must lead the charge, as highlighted at the 15th Annual Rx and Illicit Drug Summit in Nashville. Yet challenges persist: in Hennepin County, Minnesota, fentanyl was linked to 86% of opioid deaths from January to June 2025, according to a county opioid response update, even as overall trends dipped before rising mid-year.

    A new threat has emerged with medetomidine, a veterinary sedative not approved for humans, increasingly contaminating the illicit supply. The CDC's April 2 Health Alert Network advisory warns it causes profound sedation, slow heart rate, low blood pressure, and severe withdrawal symptoms like hypertension and anxiety that may require intensive care. Since fentanyl often mixes with it, naloxone remains essential for reversing overdoses by restoring breathing, the CDC advises. Meanwhile, a fresh study reveals naloxone's limitations against super-potent synthetics like fentanyl and sufentanil, with current doses sometimes failing to fully reverse overdoses, as reported in the UCAC Weekly Newsletter.

    Federal and state responses are ramping up. The Congressional Budget Office outlines strategies including disrupting illicit supply chains, boosting Medicaid coverage for treatment, expanding telehealth, aiding those in the criminal justice system, and increasing naloxone access, which have proven to cut use and overdoses. The AMA urges eliminating prior authorizations for medications like buprenorphine an

    Some great Deals https://amzn.to/49SJ3Qs

    For more check out http://www.quietplease.ai

    This content was created in partnership and with the help of Artificial Intelligence AI
    続きを読む 一部表示
    3 分
  • # US Opioid Deaths Drop 38% but Fentanyl and New Adulterants Pose Emerging Threats

    # US Opioid Deaths Drop 38% but Fentanyl and New Adulterants Pose Emerging Threats
    2026/04/19
    The opioid epidemic in the United States is showing signs of progress after years of devastation, with overdose deaths dropping significantly from over 110,000 in 2023 to around 75,000 in 2025, according to the American Medical Association. Provisional CDC data reveals an even steeper decline of nearly 38% between October 2023 and October 2025, from 109,703 to 68,408 deaths, marking 12 straight months of decreases as reported by CBS News. Listeners, this turnaround comes after a peak driven by illicitly manufactured fentanyl, which fueled the crisis, but local trends like those in Hennepin County, Minnesota, paint a mixed picture—fentanyl was involved in 86% of opioid deaths from January to June 2025, and both deaths and hospital visits rose after a 2024 downturn, per the county's April 9, 2026 update.

    Despite national gains, challenges persist. The AMA warns the epidemic is evolving into a more complex threat, with nearly 60% of 2025 deaths involving multiple substances, including emerging adulterants like medetomidine—a veterinary sedative causing profound sedation and low blood pressure, as noted in the CDC's April 2 Health Alert. Globally, the World Health Organization reports opioids drive about 450,000 of 600,000 annual drug-related deaths, affecting 61 million people with non-medical use in 2023. In the U.S., a Weill Cornell Medicine survey from January 2026 shows 88% of adults across political lines view opioid overdoses as a very serious crisis, though conservatives emphasize personal responsibility while liberals point to pharmaceutical companies.

    Funding remains volatile amid these shifts. Over $1.5 billion in State Opioid Response grants were awarded for prevention and treatment, alongside settlement funds, but SAMHSA grant disruptions and proposed 2026 budget cuts to CDC and SAMHSA threaten progress, STAT News reports. The Congressional Budget Office outlines federal strategies like boosting prescription monitoring, expanding telehealth and Medicaid for treatment, increasing naloxone access, and disrupting illicit supply chains. The AMA pushes for removing barriers to buprenorphine and methadone—prescriptions for buprenorphine jumped from 1.4 million in 2012 to 15.4 million in 2024—plus over-the-counter naloxone and parity enforcement in insurance.

    Experts at the Rx and I

    Some great Deals https://amzn.to/49SJ3Qs

    For more check out http://www.quietplease.ai

    This content was created in partnership and with the help of Artificial Intelligence AI
    続きを読む 一部表示
    3 分
  • US Opioid Deaths Drop 38% in Two Years, But Fentanyl Crisis Demands Sustained Federal Action

    US Opioid Deaths Drop 38% in Two Years, But Fentanyl Crisis Demands Sustained Federal Action
    2026/04/16
    The opioid epidemic in the United States is showing promising signs of decline, with overdose deaths dropping significantly in recent years, yet it remains a complex and deadly crisis demanding urgent action. According to the American Medical Association, opioid-related deaths fell from over 110,000 in 2023 to about 75,000 in 2025, driven largely by illicitly manufactured fentanyl and polysubstance use, where nearly 60% of fatalities involve multiple drugs. The Centers for Disease Control and Prevention reports an even steeper overall decline, with provisional data indicating a nearly 38% drop in drug overdose deaths from 109,703 in late 2023 to 68,408 by late 2025, marking 12 straight months of reductions.

    This progress stems from expanded access to treatments like buprenorphine, whose prescriptions surged from 1.4 million in 2012 to 15.4 million in 2024, as noted by the AMA. Naloxone distribution has also ramped up through over-the-counter availability, emergency departments, and community programs, saving countless lives. At the 15th Annual Rx and Illicit Drug Summit in Nashville, leaders from the AMA, American Society of Addiction Medicine, and American Pharmacists Association emphasized physician-led, team-based care to sustain these gains amid an unpredictable illicit drug supply.

    However, challenges persist. The Congressional Budget Office highlights the need for federal policies to curb supply by disrupting fentanyl trafficking, boost demand reduction through Medicaid-covered treatments and telehealth, and enhance harm reduction like overdose reversal meds. Funding uncertainties loom for 2026, with disruptions to SAMHSA grants and proposed cuts to CDC and SAMHSA programs threatening progress, warns STAT News. A Weill Cornell Medicine survey reveals 88% of Americans across political lines view opioid overdoses as a very serious crisis, though conservatives stress personal responsibility while liberals point to pharmaceutical companies.

    Public health experts like AMA President Bobby Mukkamala stress eliminating barriers such as prior authorizations for medications, expanding methadone access, and enforcing mental health parity laws. Despite deaths plateauing around 72,000 annually—still tragically high—science, evidence, and compassion must guide evolving responses to this polysubstance overdose era.

    Thank you for tuning in, listeners. Come back next week for more. This has been a Quiet Please production, and for me, check out Quiet Please Dot A I.

    Some great Deals https://amzn.to/49SJ3Qs

    For more check out http://www.quietplease.ai

    This content was created in partnership and with the help of Artificial Intelligence AI
    続きを読む 一部表示
    3 分
  • # US Opioid Deaths Drop 27% in 2024: Fentanyl Crisis Shows Signs of Improvement

    # US Opioid Deaths Drop 27% in 2024: Fentanyl Crisis Shows Signs of Improvement
    2026/04/12
    The opioid epidemic continues to ravage communities worldwide, but recent data shows a glimmer of hope in the U.S. with overdose deaths dropping sharply. According to the Centers for Disease Control and Prevention, as reported by Weill Cornell Medicine, U.S. opioid overdose deaths fell nearly 27% from 83,140 in 2023 to 54,743 in 2024, marking a significant turnaround after years of escalation driven by illicit fentanyl. The American Medical Association notes an even steeper decline, from over 110,000 opioid-related deaths in 2023 to 75,000 in 2025, though most still involve fentanyl mixed with other substances like methamphetamine or cocaine, making the drug supply more toxic than ever.

    This crisis, which has claimed over 1 million lives in the U.S. since 2000 according to SHADAC, began with overprescribing of painkillers like oxycodone in the late 1990s, quadrupled sales by 2021 per Market.us data, and exploded with synthetic opioids. Fentanyl now dominates, implicated in 69.5% of U.S. opioid overdoses in 2022 and causing rates to peak at 22.7 deaths per 100,000 in 2022. Globally, the World Health Organization reports opioids fuel about 450,000 of 600,000 annual drug deaths, with 61 million people using non-medical opioids in 2023 and fewer than 10% receiving treatment.

    Public attitudes are shifting, as a Weill Cornell Medicine survey published in JAMA Network Open reveals: 88% of Americans across political lines see opioid overdoses as a very serious problem. Conservatives emphasize personal responsibility, while liberals point to pharmaceutical companies, boosting support for lawsuits and settlement-funded programs. The AMA advocates removing barriers to treatments like buprenorphine and expanding naloxone access through pharmacies and community distribution.

    Timely interventions are gaining traction. WHO updated guidelines on April 2, 2026, for opioid dependence treatment and overdose prevention to close care gaps. North Carolina's Department of Health and Human Services held a March 27, 2026, meeting focusing on justice-involved populations. The Congressional Budget Office outlines federal strategies like enhancing prescription monitoring, telehealth for treatment, and disrupting illicit supply chains, which have reduced hospital admissions. PAHO urges integrated action in the Americas, including youth prevention and gender-responsive care amid rising synthetic opioi

    Some great Deals https://amzn.to/49SJ3Qs

    For more check out http://www.quietplease.ai

    This content was created in partnership and with the help of Artificial Intelligence AI
    続きを読む 一部表示
    3 分
  • # Opioid Deaths Drop 32% as America Turns Corner on Epidemic: What's Working

    # Opioid Deaths Drop 32% as America Turns Corner on Epidemic: What's Working
    2026/04/09
    Listeners, the opioid epidemic in America is showing unprecedented signs of progress, with overdose deaths plummeting dramatically in recent years. According to the American Medical Association, opioid-related deaths fell from over 110,000 in 2023 to 75,000 in 2025, driven largely by a crackdown on illicit fentanyl, though nearly 60% still involve multiple substances in an increasingly toxic drug supply.

    This decline builds on earlier drops: the Centers for Disease Control and Prevention reports a 27% reduction from 83,140 opioid overdoses in 2023 to 54,743 in 2024, with synthetic opioids like fentanyl—now accounting for 89% of cases—falling 37% from 2023 to 2024 per the Congressional Budget Office. CBS News noted overdose deaths slowing 18% since last year's peak, marking 12 straight months of decline as of late 2024. These shifts mark a turning point after more than a decade of escalation, where deaths quadrupled since 1999 and became the leading cause for those under 50.

    Yet challenges persist amid this evolution into a polysubstance crisis. The AMA's Substance Use and Pain Care Task Force highlights gaps in pain care, with nonopioid options still inadequate despite opioid prescriptions halving from 260 million in 2012 to 126 million in 2024. Buprenorphine prescriptions for opioid use disorder surged from 1.4 million to 15.4 million over the same period, but stigma, regulations, and insurance barriers limit access. The Congressional Budget Office outlines federal strategies like enhancing prescription drug monitoring programs, expanding Medicaid and telehealth for treatment, and boosting naloxone distribution, all proven to cut misuse, hospitalizations, and mortality.

    Public sentiment reflects urgency and nuance. A Weill Cornell Medicine survey in JAMA Network Open found 88% of Americans across political lines view opioid overdoses as a very serious crisis, though conservatives emphasize personal responsibility while liberals point to pharmaceutical companies—potentially fueling lawsuits and settlement-funded programs. North Carolina's Department of Health and Human Services, in a March 2026 meeting, focused on high-risk justice-involved populations, where overdoses spike post-release; the state expects $1.6 billion from national opioid settlements to fund diversion, treatment in corrections, and reentry support.

    Experts like AMA President Bobby Mukkamala stress decisive action: eliminate prior authorizations for treatments like bu

    Some great Deals https://amzn.to/49SJ3Qs

    For more check out http://www.quietplease.ai

    This content was created in partnership and with the help of Artificial Intelligence AI
    続きを読む 一部表示
    3 分
  • US Overdose Deaths Drop 27% as Federal Opioid Strategy Shows Real Progress in 2025

    US Overdose Deaths Drop 27% as Federal Opioid Strategy Shows Real Progress in 2025
    2026/04/05
    The opioid epidemic continues to ravage communities worldwide, but recent U.S. data shows a dramatic decline in overdose deaths, dropping from over 110,000 in 2023 to around 75,000 in 2025, according to the American Medical Association. The Centers for Disease Control and Prevention reports about 73,000 deaths in the 12 months ending August 2025, with a nearly 27% decrease from 83,140 in 2023 to 54,743 in 2024, marking a turning point after years of escalation driven by illicit fentanyl and polysubstance use.

    This progress stems from multifaceted strategies targeting supply, demand, and harm reduction. The Congressional Budget Office's January 2026 report outlines federal policies like disrupting illicit opioid supply chains to cut hospital admissions, expanding Medicaid coverage for opioid use disorder treatment, boosting telehealth access, increasing care for those in the criminal justice system, and enhancing state prescription drug monitoring programs. These approaches, building on laws like the 2016 Comprehensive Addiction and Recovery Act, have proven effective in curbing demand and overdose fatalities.

    Timely funding plays a pivotal role. The White House has allocated $1.5 billion through HHS's State Opioid Response grants to expand treatment, naloxone distribution, and recovery supports, plus $104 million for rural communities via HRSA's Rural Communities Opioid Response Program. SAMHSA added $20.5 million for recovery connections, and FDA guidance now eases naloxone access in underserved areas. Yet challenges persist: AMA highlights underuse of lifesaving medications like buprenorphine and methadone due to stigma and barriers, urging over-the-counter naloxone and parity enforcement in insurance. Funding uncertainties loom, with reports of potential $26 billion cuts under restructuring proposals, though opioid settlement funds provide a steady stream.

    Public sentiment reflects urgency, with Weill Cornell Medicine's January 2026 survey showing 88% of Americans across political lines viewing overdoses as a crisis, increasingly blaming pharmaceutical companies alongside individuals. Globally, HIFA notes 60 million affected and over 100,000 annual deaths, with discussions starting April 13, 2026, on supply controls, awareness, and harm reduction like supervised sites.

    As deaths fall, sustained investment in evidence-based care offers hope, but evolving threats demand vigilance to prevent backsliding.

    Thank you for tuning in, listeners. Come back next week for mor

    Some great Deals https://amzn.to/49SJ3Qs

    For more check out http://www.quietplease.ai

    This content was created in partnership and with the help of Artificial Intelligence AI
    続きを読む 一部表示
    3 分
  • # Opioid Deaths Decline 27% as America Makes Progress Against Epidemic, Yet 81 Lives Lost Daily

    # Opioid Deaths Decline 27% as America Makes Progress Against Epidemic, Yet 81 Lives Lost Daily
    2026/04/02
    The opioid epidemic in America is showing signs of real progress, with overdose deaths declining significantly over the past two years, though tens of thousands of lives are still being lost annually. According to the Centers for Disease Control and Prevention, opioid-related deaths dropped from over 110,000 in 2023 to approximately 72,000 to 75,000 in 2025, representing a remarkable 27 percent decrease. However, experts warn that listeners should not become complacent, as this ongoing crisis still claims more than 81 lives every single day.

    The landscape of the opioid crisis continues to shift in troubling ways. According to the American Medical Association, nearly 60 percent of opioid overdose deaths now involve multiple dangerous substances, with illicitly made fentanyl remaining the primary driver. The drug supply has become increasingly unpredictable and toxic, with fentanyl and synthetic opioids now dominating the illegal drug market. Addiction specialists report that fentanyl addiction presents unique complications that make recovery significantly more difficult than with traditional opioids, presenting new challenges for treatment providers in 2026.

    Despite these obstacles, there are encouraging developments. Prescriptions for buprenorphine, a key medication for treating opioid use disorder, have surged from 1.4 million in 2012 to 15.4 million in 2024, according to the American Medical Association. Additionally, over 1.5 billion dollars in State and Tribal Opioid Response continuation awards have been announced to support prevention, medication treatment, recovery services, and overdose reversal efforts. The Congressional Budget Office has identified multiple evidence-based policy approaches that could further reduce the crisis, including expanding Medicaid coverage for treatment, increasing access to telehealth services, and enhancing prescription drug monitoring programs.

    Public opinion reflects widespread recognition of the problem. According to researchers at Weill Cornell Medicine, approximately 88 percent of Americans across the political spectrum view opioid overdoses as a very serious problem requiring urgent action. The research also reveals a shift in how Americans assign responsibility, with growing recognition that both pharmaceutical companies and individuals bear responsibility for addressing this epidemic.

    Looking ahead, the White House has signaled renewed commitment to addiction and recovery through recent initiatives and executive actions. Federal agencies continue to invest heavily

    Some great Deals https://amzn.to/49SJ3Qs

    For more check out http://www.quietplease.ai

    This content was created in partnership and with the help of Artificial Intelligence AI
    続きを読む 一部表示
    3 分